Home › Stocks › PPCB

PPCB — PROPANC BIOPHARMA INC

Reported value held$127.26K
Funds holding (latest)15
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q3 2026)4
Institutional value$38.21K · 77.21K sh
New / Add / Cut / Exit3 / 1 / 0 / 3 · Updated 2026-11-13
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +119.6% (+30.57K sh)
Institutional value change Down -27.7%

Fundamentals (SEC EDGAR XBRL)

Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.

Revenue TTM Revenue YoY Net income TTM Net income YoY ROE (TTM) Gross margin Net margin P/E (TTM) P/E pct P/B P/B pct
— — — — — — — — — — —

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

As of Q3 2026, 4 SEC-registered investment managers reported holding PPCB (PROPANC BIOPHARMA INC) in their latest 13F filings, with a combined reported value of $38.21K across 77.21K shares. That is +119.6% by share count (+30.57K shares) versus the previous quarter, while reported value moved -27.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

Compared with the prior quarter, 3 opened new positions, 1 added to existing stakes, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.

Major shareholders of PROPANC BIOPHARMA INC (PPCB) include JANE STREET GROUP, LLC, UBS Group AG, Citadel Advisors, ranked by reported 13F value among the 15 institutional holders on this page.

PPCB is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 4 77.21K $38.21K +119.6%
Q2 2026 4 47.88K $71.46K -82.2%
Q1 2026 6 462.40K $48.69K -8.4%
Q4 2025 5 128.89K $69.47K -7.7%
Q3 2025 3 112.11K $190.73K —

Over the 5 quarters shown, institutional share counts decreased 31% in aggregate (Q3 2025 → Q3 2026); the largest single-quarter swing was Q2 2026 (-82.2%).

Top Institutional Holders (Q3 2026) — 4 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 56.12K $27.72K 0.00% Add
StoneX Group Inc. 11.09K $5.54K 0.00% New
BANK OF MONTREAL /CAN/ 10.00K $4.94K 0.00% New
JPMorgan Chase & Co 5 $3 0.00% New

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 4 funds

FundSharesValuePortfolio WeightChange
JANE STREET GROUP, LLC 25.55K $38.32K 0.00% Reduce
Citadel Advisors 12.09K $18.14K 0.00% New
HRT FINANCIAL LP 10.24K $15.00K 0.00% New
Caitong International Asset Management Co., Ltd 2 $3 0.00% New

Q1 2026 — 6 funds

FundSharesValuePortfolio WeightChange
UBS Group AG 182.61K $19.36K 0.00% New
JANE STREET GROUP, LLC 143.21K $15.18K 0.00% New
Marex Group Ltd 67.72K $7.18K 0.00% Add
Virtu Financial LLC 40.75K $4.00K 0.00% New
Sassicaia Capital Advisers LLC 16.00K $1.70K 0.00% New
XTX Topco Ltd 12.10K $1.28K 0.00% Reduce

Q4 2025 — 5 funds

FundSharesValuePortfolio WeightChange
Marex Group Ltd 65.02K $35.12K 0.00% Reduce
TWO SIGMA SECURITIES, LLC 25.48K $13.67K 0.00% New
XTX Topco Ltd 22.13K $11.95K 0.00% New
Two Sigma Investments 16.26K $8.72K 0.00% New
Morgan Stanley 1 $1 0.00% Hold

Q3 2025 — 3 funds

FundSharesValuePortfolio WeightChange
Marex Group Ltd 70.43K $119.73K 0.00% New
Virtu Financial LLC 41.68K $71.00K 0.00% New
Morgan Stanley 1 $2 0.00% New

New Positions (Q3 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 15 funds)

FundQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
JANE STREET GROUP, LLC 56.12K 25.55K 143.21K — —
StoneX Group Inc. 11.09K — — — —
BANK OF MONTREAL /CAN/ 10.00K — — — —
JPMorgan Chase & Co 5 — — — —
Marex Group Ltd — — 67.72K 65.02K 70.43K
Virtu Financial LLC — — 40.75K — 41.68K
UBS Group AG — — 182.61K — —
Citadel Advisors — 12.09K — — —
HRT FINANCIAL LP — 10.24K — — —
TWO SIGMA SECURITIES, LLC — — — 25.48K —
XTX Topco Ltd — — 12.10K 22.13K —
Two Sigma Investments — — — 16.26K —
Sassicaia Capital Advisers LLC — — 16.00K — —
Caitong International Asset Management Co., Ltd — 2 — — —
Morgan Stanley — — — 1 1

Download holders (CSV)

FAQ

Which funds hold PPCB?

As of 2026-Q3, 4 institutional funds reported holding PPCB (PROPANC BIOPHARMA INC) in SEC 13F filings, with a combined reported value of $38.21K.

How many shares of PPCB do institutions own?

13F filers reported 77.21K shares of PPCB, worth $38.21K in aggregate at the end of 2026-Q3.

Is institutional ownership of PPCB rising or falling?

Share counts moved +119.6% versus the prior quarter — accumulation.

Who are the top institutional holders of PPCB?

The largest 13F holders are JANE STREET GROUP, LLC, UBS Group AG, Citadel Advisors, HRT FINANCIAL LP, TWO SIGMA SECURITIES, LLC; the top 25 are ranked at the top of this page.

Who are the major shareholders of PROPANC BIOPHARMA INC?

The major shareholders of PROPANC BIOPHARMA INC (PPCB) by reported 13F value are JANE STREET GROUP, LLC, UBS Group AG, Citadel Advisors, HRT FINANCIAL LP, TWO SIGMA SECURITIES, LLC, among 15 institutional holders.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own PPCB" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/PPCB/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →